| 貨號(hào) |
中文名稱 |
英文名詞 |
靶點(diǎn) |
|
VAPD00154 |
羅妥木單抗
|
Research Grade Robatumumab Biosimilar? |
IGF1R, CD221 |
|
VAPD00153 |
Research Grade burfiralimab Biosimilar?
|
Research Grade burfiralimab Biosimilar? |
VIM, Vimentin |
|
VAPD00152 |
硫索單抗
|
Research Grade sulesomab Biosimilar? |
CEACAM6, NCA, CD66c |
|
VAPD00151 |
阿塞珠單抗
|
Research Grade Aselizumab Biosimilar? |
CD62L |
|
VAPD00150 |
普林木單抗
|
Research Grade Pritumumab Biosimilar? |
VIM, Vimentin |
|
VAPD00149 |
比伐珠單抗
|
Research Grade Bivatuzumab Biosimilar? |
CD44 |
|
VAPD00148 |
帕他莫單抗
|
Research Grade Taplitumomab Biosimilar? |
CD19 |
|
VAPD00147 |
來(lái)馬索單抗
|
Research Grade Lemalesomab Biosimilar? |
CEACAM6, NCA, CD66c |
|
VAPD00146 |
厄利珠單抗
|
Research Grade Erlizumab Biosimilar? |
ITGB2, CD18, MFI7, Integrin beta-2 |
|
VAPD00145 |
伐利昔單抗
|
Research Grade Vapaliximab Biosimilar? |
AOC3, VAP1, SSAO,Vascular adhesion protein 1 |
